Last update:

Gerontology & Geriatrics news

Medical economics

Informal caregiving for seniors in Singapore valued at S$1.28 billion annually

The monetary value of the substantial time that informal caregivers in Singapore spend looking after seniors aged 75 years and above, comes up to around S$1.28 billion annually—equivalent to about 11% of the government's ...

Health

How untreated hearing loss can result in a negative health spiral

Hearing loss is often thought of as a normal part of aging, but recent studies have shown untreated hearing loss can significantly affect overall health. Dr. Nicholas Deep, a Mayo Clinic otolaryngologist, explains how untreated ...

Medical research

Bone fracture rates in women found to vary dramatically by race

A new paper finds that bone fracture rates in older women differ by race, quite significantly. While researchers have known for years that the risk of bone fracture is highest for White women, this is the first study to show ...

Gerontology & Geriatrics

Recalibrating principles of epigenetic aging clocks in human health

As detailed in the opening of this editorial, DNA methylation-based epigenetic clocks are used as biomarkers of biological age in human health. Multiple epigenetic clocks have rapidly emerged in the past decade by modeling ...

Gerontology & Geriatrics

Q&A: Staying safe as we age—understanding falls in older adults

Falls are a major concern for older adults and for those that love and care for them. They are a leading cause of injury for adults older than 65, according to the U.S. Centers for Disease Control and Prevention. More than ...

Gerontology & Geriatrics

What does 'male menopause' mean?

Hormone changes are a natural part of aging, but the experience is different for men and women. Unlike the more dramatic plunge that occurs in women during menopause, sex hormone changes in men occur gradually. This is sometimes ...

Alzheimer's disease & dementia

Predicting Alzheimer's dementia in oldest of the old

A new study indicates that severity of amyloid deposition in the brain—not just age—may be key to determining who will benefit from new anti-amyloid therapies to delay the progression of Alzheimer's disease.